TITLE

Estrogen plus progestin reduced risk for fracture in postmenopausal women

PUB. DATE
May 2004
SOURCE
ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p61
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on the role of estrogen plus progestin to reduce the risk for fracture in postmenopausal women. Analysis was by intention to treat. Fewer women in the hormone therapy group than in the placebo group had a fracture. The effect for total fracture risk remained constant across different subgroups. When treatment effects on other important outcomes were included in a global model, hormone therapy had no net benefit, even in women with high risk for fracture. In a global model assessing treatment effects on all outcomes, hormone therapy had no net benefit.
ACCESSION #
13221824

 

Related Articles

  • Oestrogen plus progestin reduced risk of fracture in postmenopausal women. Cauley, J. A.; Robbins, J.; Chen, Z. // Evidence Based Medicine;May/Jun2004, Vol. 9 Issue 3, p82 

    The article discusses effects of oestrogen plus progestin in reducing the risk of fracture in postmenopausal women. Women above 50 and an intact uterus in the hormone therapy group than in the placebo group had a fracture. The effect of total fracture risk remained constant across different...

  • Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women. Chlebowski, Rowan T.; Wactawski-Wende, Jean; Ritenbaugh, Cheryl; Hubbell, F. Allan; Ascensao, Joao; Rodabough, Rebecca J.; Rosenberg, Carol A.; Taylor, Victoria M.; Harris, Randall; Chen, Chu; Adams-Campbell, Lucile L.; White, Emily // New England Journal of Medicine;3/4/2004, Vol. 350 Issue 10, p991 

    Background: Although the Women's Health Initiative (WHI) trial of estrogen plus progestin in postmenopausal women identified more overall health risks than benefits among women in the hormone group, the use of estrogen plus progestin was associated with a significant decrease in the risk of...

  • Estrogen plus progestin reduced risk for fracture in postmenopausal women: COMMENTARY. Papaioannou, Alexandra // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p61 

    The authors, using a global index, confirmed there was no net benefit of estrogen and progestin therapy even in women at high risk for fracture. However, the global index did not include such factors as the risk for dementia and the increase of gynecologic diagnostic procedures because of...

  • HRT does not prevent heart disease. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);8/16/2003, Vol. 327 Issue 7411, p359 

    Discusses how hormone replacement therapy (HRT) does not prevent coronary heart disease. Consideration of a medical trial that compared the combined estrogen and progestogen treatment with placebo; Risk of myocardial infarction and death in women who were given a placebo; Role of oestrogen in...

  • Hormone Replacement Therapy in Healthy Women. Huffman, Grace Brooke // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2150 

    Presents abstracts of studies on hormone replacement therapy, published on the July 17, 2002 issue of the 'Journal of the American Medical Association.' 'Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative...

  • Oestrogen plus progestin increased risk of stroke and probable dementia in postmenopausal women. Wassertheil-Smoller, S.; Hendrix, S. L.; Limacher, M.; Shumaker, S. A.; Legault, C.; Rapp, S. R.; Espeland, M. A. // Evidence Based Medicine;Nov2003, p170 

    The article focuses on a study concerning estrogen plus progestin which increased the risk of stroke and probable dementia in postmenopausal women in postmenopausal women. Respondents are 50 to 79 years old that underwent hormone replacement therapy (HRT). It mentions the Women's Health...

  • Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women. Guirguis-Blake, Janelle // American Family Physician;12/15/2005, Vol. 72 Issue 12, p2520 

    Presents questions and answers related to the use of hormone therapy for the prevention of chronic conditions in postmenopausal women. Advice of the U.S. Preventive Services Task Force regarding the routine use of combined estrogen and progestin for prevention of chronic conditions in...

  • Hot Papers in the Literature.  // Journal of Women's Health (15409996);Mar2003, Vol. 12 Issue 2, p193 

    The article discusses several studies related to women health. According to a study incidence of invasive lobular carcinoma has been increasing among post-menopausal women in some parts of the U.S. Part of this may be due to changes in classification over time. However, the use of combined...

  • Timing of follow-up densitometry in hormone replacement therapy users for optimal osteoporosis prevention. Checa, Miguel A.; Rio, L. Del; Rosales, J.; Nogués, X.; Vila, J.; Carreras, R. // Osteoporosis International;Aug2005, Vol. 16 Issue 8, p937 

    The objectives of the study were (1) to determine the time interval for repeat dual-energy X-ray absorptiometry (DXA) to detect significant bone loss, i.e., greater than the coefficient of variation (CV) of the center (2.8 × CV%) and (2) to assess how long hormone replacement therapy can be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics